¼±ÐÔÁ£Ï¸°û°×Ѫ²¡ ÖÎÁƼ±ÐÔÁ£Ï¸°û°×Ѫ²¡ ±±¾©ÑªÒº²¡Ò½Ôº
¼±ÐÔÔçÓ×Á£Ï¸°ûÐÔ°×Ѫ²¡ÊǸ÷ÖÖ°×Ѫ²¡ÖÐ×îÐ×ÏÕµÄÀàÐÍÖ®Ò»£¬ÑÏÖØÓ°Ï컼ÕßµÄÕý³£Éú»îÓëÉç½»¡£Òò´Ë£¬ÐèÔçÈÕÁ˽âÆä·¢²¡Ö¢×´²¢»ý¼«ÖÎÁÆÊǹؼü£¬ÒÔÏÂÄÚÈÝÊǼ±ÐÔÔçÓ×Á£Ï¸°û°×Ѫ²¡µÄ³£¼ûµÄÖ¢×´±íÏÖ¡£
¼±ÐÔÔçÓ×Á£Ï¸°û°×Ѫ²¡µÄÖ¢×´£º
¼±ÐÔÔçÓ×Á£Ï¸°û°×Ѫ²¡µÄÁÙ´²±íÏÖÕý³£¹ÇËèÔìѪ¹¦ÄÜË¥½ßÏà¹ØµÄ±íÏÖ£¬ÈçƶѪ¡¢³öѪ¡¢¸ÐȾ;°×Ѫ²¡Ï¸°ûµÄ½þÈóÓйصıíÏÖ£¬Èç¸ÎÆ¢ºÍÁܰͽáÖ×´ó¡¢¹ÇÍ´µÈ¡£³ýÁËÕâЩ°×Ѫ²¡¾ßÓеÄÒ»°ã°×Ѫ²¡±íÏÖÍ⣬³öѪÇãÏòÊÇÆäÖ÷ÒªµÄÁÙ´²Ìص㣬ÓÐ10%¡«20%µÄ»¼ÕßËÀÓÚÔçÆÚ³öѪ£¬ÃÖÂþÐÔѪ¹ÜÄÚÄýѪ(DIC)µÄ·¢ÉúÂʸߣ¬´óÔ¼60%µÄ»¼Õß·¢ÉúDIC¡£
¸ù¾ÝFABµÄÐÎ̬ѧÕï¶Ï±ê׼ȷÁ¢Õï¶Ï¡£°´FAB·ÖÐͼ±ÐÔÔçÓ×Á£Ï¸°û°×Ѫ²¡(acute promyelocytic leukemia£¬APL)ÓÖ³ÆAML-M3ÐÍ¡£ÆäµäÐÍÌØÕ÷ÓУº¢Ù¹ÇËèÐÎ̬Ϊ°ûÖʺ¬´Ö´ó¿ÅÁ£ºÍAuerСÌå(Ò²ÓÐ΢¿ÅÁ£±äÒìÐÍ)µÄÒì³£ÔçÓ×Á£Ï¸°ûÔöÉú;¢ÚÁÙ´²³£ÓÐÑÏÖسöѪ£¬ÇÒÒ׺ϲ¢DICºÍÏËάµ°°×Èܽâ;¢Û90%µÄ»¼ÕßÏÔʾÌØÒìÐÔȾɫÌåÒìλt(15;17);¢Ü»¯ÁÆÃô¸Ð(»¯ÁÆÄÍÒ©·¢ÉúÂÊ<5%)£¬»º½âÉú´æÆÚ³¤£¬µ«ÔçÆÚËÀÍöÂʸߡ£
¼±ÐÔÔçÓ×Á£Ï¸°û°×Ѫ²¡µÄ²¢·¢Ö¢£º
1¡¢¸ÐȾÊÇ×î³£¼ûµÄ²¢·¢Ö¢£º°üÀ¨Ï¸¾ú£¬²¡¶¾£¬Õæ¾ú¸ÐȾ£¬Ö÷Òª±íÏÖΪ·¢ÈÈ£¬¸ÐȾµÄ²¿Î»³£¼ûÓÚ¿ÚÇ»£¬·Î²¿£¬Æ¤·ô£¬ÑÏÖØÕ߿ɳöÏÖ°ÜѪ֢£¬¸ÐȾÖж¾ÐÔÐÝ¿Ë¡£
2¡¢DICÊÇAPL×îÖØÒªµÄ²¢·¢Ö¢£º·¢ÉúÂʸߣ¬´óÔ¼60%µÄ»¼Õß·¢Éú£¬½üÄêËæ×ÅÓ¦Óü×ËáºÍÉé¼Á£¬DICµÄ·¢ÉúÒÑÃ÷ÏÔ¼õµÍ¡£
3¡¢ÔÚÓ¦ÓÃάAËáÖÎÁƹý³ÌÖлáºÏ²¢¸ß°×ϸ°ûÖ¢£ºÎ¬AËá×ÛºÏÕ÷£¬¿Éͬʱ¸øÓèôÇ»ùë壬С¼ÁÁ¿Ara-C»ò¼õÁ¿µÄAA£¬DA·½°¸ÖÎÁÆ¡£
¼±ÐÔÔçÓ×Á£Ï¸°û°×Ѫ²¡µÄÔ¤ºóЧ¹û£º
ÒÔÍùAPLµÄÖÎÁÆЧ¹û²î£¬²¡ÇéÐ×ÏÕ£¬Ëæ×ŶÔAPLµÄϸ°ûÉúÎïѧµÄÌØÐÔÈÏʶµÄ²»¶ÏÌá¸ßºÍÖÎÁÆ·½·¨µÄ¸Ä½ø£¬Ê¹ÖÎÁƽá¹ûºÍÔ¤ºóÓÐÁ˺ܴóµÄ¸ÄÉÆ£¬ÔçÆÚËÀÍöÂÊÃ÷ÏÔϽµ£¬³ÖÐø»º½âʱ¼äÑÓ³¤£¬ÊÇÄ¿Ç°°×Ѫ²¡ÖÎÁÆЧ¹û×îºÃµÄÒ»ÖÖÀàÐÍ¡£
ÔÚÈÕ³£Éú»î»ò¹¤×÷ÖУ¬²»Òª¹ý¶àµØ½Ó´¥XÉäÏߺÍÆäËûÓк¦µÄ·ÅÉäÏß¡£´ÓÊ·ÅÉäÏß¹¤×÷µÄÈËÔ±Òª×öºÃ¸öÈ˵ķÀ»¤£¬¼ÓÇ¿Ô¤·À´ëÊ©¡£ÁíÍ⣬ҹÍí˯¾õÌ«Íí»ò¾³£¼ÓÒ¹°à»áÔö¼Ó»¼°×Ѫ²¡¼¸ÂÊ¡£°×Ѫ²¡·¢²¡ÂÊÔö¶àÓëÒ¹Íí±©Â¶ÔڵƹâÏÂÓйØϵ¡£